Pharmacokinetic of Posaconazole in Critically Ill Patients

Universitätsklinikum Hamburg-Eppendorf

Status: Completed

Conditions: Therapeutic Drug Monitoring; Critical Illness

Treatments: Other: Posaconazole Therapeutic Drug Monitoring

Study type: Observational

Funder types: Other

Identifiers

NCT05275179

PV7263

Details and patient eligibility

About

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.

Full description

The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial. Plasma specimens will be retrieved on consecutive days (max. 7 days) in order to measure posaconazole levels during the treatment episode.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• treatment with intravenous posaconazole
• critically ill patient
• written declaration of consent

Exclusion criteria

• no declaration of consent

Trial design

10 participants in 1 patient group

Posaconazole Therapeutic Drug Monitoring

Description:

Therapeutic Drug Monitoring of posaconzole is performed by measuring posaconazole concentrations in serum

Treatment:

Other: Posaconazole Therapeutic Drug Monitoring